Simms John, Hay Debbie L, Wheatley Mark, Poyner David R
School of Life and Health Sciences, Aston University, Birmingham, United Kingdom.
Biophys J. 2006 Jul 15;91(2):662-9. doi: 10.1529/biophysj.106.084582. Epub 2006 Apr 21.
Receptor activity modifying proteins (RAMPs) are a family of single-pass transmembrane proteins that dimerize with G-protein-coupled receptors. They may alter the ligand recognition properties of the receptors (particularly for the calcitonin receptor-like receptor, CLR). Very little structural information is available about RAMPs. Here, an ab initio model has been generated for the extracellular domain of RAMP1. The disulfide bond arrangement (Cys27-Cys82, Cys40-Cys72, and Cys57-Cys104) was determined by site-directed mutagenesis. The secondary structure (alpha-helices from residues 29-51, 60-80, and 87-100) was established from a consensus of predictive routines. Using these constraints, an assemblage of 25,000 structures was constructed and these were ranked using an all-atom statistical potential. The best 1000 conformations were energy minimized. The lowest scoring model was refined by molecular dynamics simulation. To validate our strategy, the same methods were applied to three proteins of known structure; PDB:1HP8, PDB:1V54 chain H (residues 21-85), and PDB:1T0P. When compared to the crystal structures, the models had root mean-square deviations of 3.8 A, 4.1 A, and 4.0 A, respectively. The model of RAMP1 suggested that Phe93, Tyr100, and Phe101 form a binding interface for CLR, whereas Trp74 and Phe92 may interact with ligands that bind to the CLR/RAMP1 heterodimer.
受体活性修饰蛋白(RAMPs)是一类单次跨膜蛋白家族,可与G蛋白偶联受体二聚化。它们可能会改变受体的配体识别特性(特别是对于降钙素受体样受体,CLR)。关于RAMPs的结构信息非常少。在此,已为RAMP1的胞外域生成了一个从头算模型。通过定点诱变确定了二硫键排列(Cys27-Cys82、Cys40-Cys72和Cys57-Cys104)。二级结构(来自残基29-51、60-80和87-100的α螺旋)是根据预测程序的共识确定的。利用这些限制条件,构建了25000个结构的集合,并使用全原子统计势对它们进行排序。对得分最高的1000个构象进行了能量最小化。通过分子动力学模拟对得分最低的模型进行了优化。为了验证我们的策略,将相同的方法应用于三种已知结构的蛋白质;PDB:1HP8、PDB:1V54链H(残基21-85)和PDB:1T0P。与晶体结构相比,这些模型的均方根偏差分别为3.8 Å、4.1 Å和4.0 Å。RAMP1模型表明,Phe93、Tyr100和Phe101形成了CLR的结合界面,而Trp74和Phe92可能与结合到CLR/RAMP1异二聚体的配体相互作用。